MedImmune Ventures, Inc., 10% Owner at G1 Therapeutics, Inc. (GTHX), bought 75,000 shares at $15.00 ($1.1M) on 2017-05-17, disclosed to the SEC on 2017-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2017-11-22 | $8.0M | — | Filing → |
| GTHX | BUY | 2017-05-24 | $1.1M | — | Filing → |
| CATB | BUY | 2015-06-30 | $2.7M | — | Filing → |